Literature DB >> 21615193

Stress, allostatic load, catecholamines, and other neurotransmitters in neurodegenerative diseases.

D S Goldstein1.   

Abstract

As populations age, the prevalence of geriatric neurodegenerative diseases will increase. These diseases generally are multifactorial, arising from complex interactions among genes, environment, concurrent morbidities, treatments, and time. This essay provides a concept for the pathogenesis of Lewy body diseases such as Parkinson disease, by considering them in the context of allostasis and allostatic load. Allostasis reflects active, adaptive processes that maintain apparent steady states, via multiple interacting effectors regulated by homeostatic comparators-"homeostats." Stress can be defined as a condition or state in which a sensed discrepancy between afferent information and a setpoint for response leads to activation of effectors, reducing the discrepancy. "Allostatic load" refers to the consequences of sustained or repeated activation of mediators of allostasis. From the analogy of an idling car, the revolutions per minute of the engine can be maintained at any of a variety of levels (allostatic states). Just as allostatic load (cumulative wear and tear) reflects design and manufacturing variations, byproducts of combustion, and time, eventually leading to engine breakdown, allostatic load in catecholaminergic neurons might eventually lead to Lewy body diseases. Central to the argument is that catecholamines in the neuronal cytoplasm are autotoxic and that catecholamines from storage visicles leak into the cytoplasm continuously during life. These neurons therefore depend on vesicular sequestration to limit autotoxicity of cytosolic transmitter. Parkinson disease might be a disease of the elderly because of allostatic load, which depends on genetic predispositions, environmental exposures, repeated stress-related catecholamine release, and time.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615193      PMCID: PMC5241091          DOI: 10.4149/endo_2011_02_91

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  17 in total

1.  Catechols in post-mortem brain of patients with Parkinson disease.

Authors:  D S Goldstein; P Sullivan; C Holmes; I J Kopin; M J Basile; D C Mash
Journal:  Eur J Neurol       Date:  2010-11-12       Impact factor: 6.089

2.  Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.

Authors:  William J Burke; Vijaya B Kumar; Neeraj Pandey; W Michael Panneton; Qi Gan; Mark W Franko; Mark O'Dell; Shu Wen Li; Yi Pan; Hyung D Chung; James E Galvin
Journal:  Acta Neuropathol       Date:  2007-10-27       Impact factor: 17.088

3.  Alpha-synuclein overexpression increases cytosolic catecholamine concentration.

Authors:  Eugene V Mosharov; Roland G W Staal; Jordi Bové; Delphine Prou; Anthonia Hananiya; Dmitriy Markov; Nathan Poulsen; Kristin E Larsen; Candace M H Moore; Matthew D Troyer; Robert H Edwards; Serge Przedborski; David Sulzer
Journal:  J Neurosci       Date:  2006-09-06       Impact factor: 6.167

4.  Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension.

Authors:  Yehonatan Sharabi; Richard Imrich; Courtney Holmes; Sandra Pechnik; David S Goldstein
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

Review 5.  Leaky catecholamine stores: undue waste or a stress response coping mechanism?

Authors:  Graeme Eisenhofer; Irwin J Kopin; David S Goldstein
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

6.  Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication.

Authors:  Amanda Singleton; Katrina Gwinn-Hardy; Yehonotan Sharabi; Sheng-Ting Li; Courtney Holmes; Raghuveer Dendi; John Hardy; Andrew Singleton; Anthony Crawley; David S Goldstein
Journal:  Brain       Date:  2004-01-21       Impact factor: 13.501

7.  Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol.

Authors:  Jennifer N Rees; Virginia R Florang; Laurie L Eckert; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2009-07       Impact factor: 3.739

8.  Mussel-inspired surface chemistry for multifunctional coatings.

Authors:  Haeshin Lee; Shara M Dellatore; William M Miller; Phillip B Messersmith
Journal:  Science       Date:  2007-10-19       Impact factor: 47.728

9.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15

10.  The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.

Authors:  W Michael Panneton; V B Kumar; Qi Gan; William J Burke; James E Galvin
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

View more
  14 in total

Review 1.  How does homeostasis happen? Integrative physiological, systems biological, and evolutionary perspectives.

Authors:  David S Goldstein
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-01-16       Impact factor: 3.619

Review 2.  Stress regulates endocannabinoid-CB1 receptor signaling.

Authors:  Cecilia J Hillard
Journal:  Semin Immunol       Date:  2014-05-29       Impact factor: 11.130

3.  Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways.

Authors:  L N Saligan; C P Hsiao; D Wang; X M Wang; L St John; A Kaushal; D Citrin; J J Barb; P J Munson; R A Dionne
Journal:  Brain Behav Immun       Date:  2012-09-26       Impact factor: 7.217

4.  RTP801 is a critical factor in the neurodegeneration process of A53T α-synuclein in a mouse model of Parkinson's disease under chronic restraint stress.

Authors:  Zhao Zhang; Shi-Feng Chu; Sha-Sha Wang; Yi-Na Jiang; Yan Gao; Peng-Fei Yang; Qi-Di Ai; Nai-Hong Chen
Journal:  Br J Pharmacol       Date:  2018-01-17       Impact factor: 8.739

Review 5.  Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky.

Authors:  David S Goldstein; Irwin J Kopin
Journal:  Cell Mol Neurobiol       Date:  2017-05-09       Impact factor: 5.046

6.  Progressive Degeneration and Adaptive Excitability in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons Exposed to HIV-1 Tat and Morphine.

Authors:  Arianna R S Lark; Lindsay K Silva; Sara R Nass; Michael G Marone; Michael Ohene-Nyako; Therese M Ihrig; William D Marks; Viktor Yarotskyy; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  Cell Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.046

7.  Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.

Authors:  Luana Palazzi; Benedetta Fongaro; Manuela Leri; Laura Acquasaliente; Massimo Stefani; Monica Bucciantini; Patrizia Polverino de Laureto
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

8.  Stress and Corticosteroids Modulate Muscarinic Long Term Potentiation (mLTP) in the Hippocampus.

Authors:  Efrat Shavit Stein; Ze'Ev Itsekson Hayosh; Andreas Vlachos; Nicola Maggio
Journal:  Front Cell Neurosci       Date:  2017-09-21       Impact factor: 5.505

9.  Monitoring the Secretory Behavior of the Rat Adrenal Medulla by High-Performance Liquid Chromatography-Based Catecholamine Assay from Slice Supernatants.

Authors:  Frédéric De Nardi; Claudie Lefort; Dimitri Bréard; Pascal Richomme; Christian Legros; Nathalie C Guérineau
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-25       Impact factor: 5.555

10.  The Impact of COVID-19 Pandemic on Disease Severity and Quality of Life in Parkinson's Disease.

Authors:  Alvee Saluja; Jasmine Parihar; Divyani Garg; Rajinder K Dhamija
Journal:  Ann Indian Acad Neurol       Date:  2021-04-05       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.